Sitagliptin/metforminklorid APC 100 mg/1000 mg tablete s prilagođenim oslobađanjem Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sitagliptin/metforminklorid apc 100 mg/1000 mg tablete s prilagođenim oslobađanjem

apc instytut sp. z o.o., ul. aleje jerozolimskie 146c, varšava, mazowieckei, poljska - sitagliptinklorid hidrat metforminklorid - tableta s prilagođenim oslobađanjem - urbroj: svaka tableta sadrži 100 mg sitagliptina u obliku sitagliptinklorid hidrata i 1000 mg metforminklorida

Sitagliptin/metforminklorid APC 50 mg/1000 mg tablete s prilagođenim oslobađanjem Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sitagliptin/metforminklorid apc 50 mg/1000 mg tablete s prilagođenim oslobađanjem

apc instytut sp. z o.o., ul. aleje jerozolimskie 146c, varšava, mazowieckei, poljska - sitagliptinklorid hidrat metforminklorid - tableta s prilagođenim oslobađanjem - urbroj: svaka tableta sadrži 50 mg sitagliptina u obliku sitagliptinklorid hidrata i 1000 mg metforminklorida

Sitagliptin/metforminklorid APC 50 mg/500 mg tablete s prilagođenim oslobađanjem Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sitagliptin/metforminklorid apc 50 mg/500 mg tablete s prilagođenim oslobađanjem

apc instytut sp. z o.o., ul. aleje jerozolimskie 146c, varšava, mazowieckei, poljska - sitagliptinklorid hidrat metforminklorid - tableta s prilagođenim oslobađanjem - urbroj: svaka tableta sadrži 50 mg sitagliptina u obliku sitagliptinklorid hidrata i 500 mg metforminklorida.

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Europska Unija - hrvatski - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 za dostupne podatke o različitim kombinacijama).

Metformin Alkaloid 1000 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

metformin alkaloid 1000 mg filmom obložene tablete

alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - metforminklorid - filmom obložena tableta - 1000 mg - urbroj: jedna filmom obložena tableta sadrži 1000 mg metforminklorida

Metformin Alkaloid 500 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

metformin alkaloid 500 mg filmom obložene tablete

alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - metforminklorid - filmom obložena tableta - 500 mg - urbroj: jedna filmom obložena tableta sadrži 500 mg metforminklorida

Metformin Alkaloid 850 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

metformin alkaloid 850 mg filmom obložene tablete

alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - metforminklorid - filmom obložena tableta - 850 mg - urbroj: jedna filmom obložena tableta sadrži 850 mg metforminklorida

Vildagliptin / Metformin hydrochloride Accord Europska Unija - hrvatski - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 za dostupne podatke o različitim kombinacijama).

Sitagliptin / Metformin hydrochloride Accord Europska Unija - hrvatski - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. trostruki kombinovanu terapiju) kao dodatak prehrani i vježbe kod pacijenata, nedovoljno kontroliranim o njihovo maksimalno переносимой doze метформина i sulfonilurejom. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.